<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Capital Markets &#8211; Edoardo Ricci Avvocati</title>
	<atom:link href="https://edoardoricci.com/en/category/corporate/capital-markets-en/feed/" rel="self" type="application/rss+xml" />
	<link>https://edoardoricci.com/en/</link>
	<description>Boutique Law Firm in Milan</description>
	<lastBuildDate>Mon, 13 Jul 2020 18:26:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
	<item>
		<title>Edoardo Ricci advised Cassiopea S.p.A. on share capital increase</title>
		<link>https://edoardoricci.com/en/edoardo-ricci-advised-cassiopea-s-p-a-on-share-capital-increase/</link>
		
		<dc:creator><![CDATA[edoardoricci]]></dc:creator>
		<pubDate>Sat, 11 Jul 2020 16:00:44 +0000</pubDate>
				<category><![CDATA[Capital Markets]]></category>
		<category><![CDATA[Corporate]]></category>
		<guid isPermaLink="false">https://edoardoricci.com/?p=2957</guid>

					<description><![CDATA[A team composed of our partner Gabriele Prenna and associate Giovanni Gerbini assisted Cassiopea S.p.A., a pharmaceutical company focused on biotechnology and listed on the SIX Swiss Exchange, on recently completed share capital increase. Company&#8217;s shareholders were offered 750.000 newly issued ordinary shares with nominal value of € 1.00 and subscription price of € 31.00 [&#8230;]]]></description>
										<content:encoded><![CDATA[
<p>A team composed of our partner Gabriele Prenna and associate Giovanni Gerbini assisted Cassiopea S.p.A., a pharmaceutical company focused on biotechnology and listed on the SIX Swiss Exchange, on recently completed share capital increase.</p>



<p>Company&#8217;s shareholders were offered 750.000 newly issued ordinary shares with nominal value of € 1.00 and subscription price of € 31.00 each.</p>



<p>The offer period started on 3 June and ended on 17 June with the full subscription of the new capital for a total value of € 23. 250.000 including share premium, resulting in the capital increase up to the nominal value of € 10.750.000.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
